Literature DB >> 17229864

PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia.

R Fotedar1, D Stark, N Beebe, D Marriott, J Ellis, J Harkness.   

Abstract

This study investigated the presence of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from a patient population in Sydney, Australia. Stool samples were tested by microscopy and PCR. Five patients were found with E. histolytica infections, while E. dispar and E. moshkovskii were observed in 63 (70.8%) and 55 (61.8%) patients, respectively, by PCR. This is the first study in Australia using molecular techniques to determine the presence of E. histolytica, E. dispar, and E. moshkovskii.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229864      PMCID: PMC1829108          DOI: 10.1128/JCM.02144-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Estimating the impact of amebiasis on health.

Authors:  W A Petri; R Haque; D Lyerly; R R Vines
Journal:  Parasitol Today       Date:  2000-08

2.  Differential detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii by a single-round PCR assay.

Authors:  Zulhainan Hamzah; Songsak Petmitr; Mathirut Mungthin; Saovanee Leelayoova; Porntip Chavalitshewinkoon-Petmitr
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  The Laredo strain and other 'Entamoeba histolytica-like' amoebae are Entamoeba moshkovskii.

Authors:  C G Clark; L S Diamond
Journal:  Mol Biochem Parasitol       Date:  1991-05       Impact factor: 1.759

4.  PCR differentiation of Entamoeba histolytica and Entamoeba dispar from patients with amoeba infection initially diagnosed by microscopy.

Authors:  Marianne Lebbad; Staffan G Svärd
Journal:  Scand J Infect Dis       Date:  2005

5.  Entamoeba moshkovskii and Entamoeba dispar-associated infections in pondicherry, India.

Authors:  Subhash Chandra Parija; Krishna Khairnar
Journal:  J Health Popul Nutr       Date:  2005-09       Impact factor: 2.000

6.  Present characteristics of symptomatic Entamoeba histolytica infection in the big cities of Japan.

Authors:  K Ohnishi; Y Kato; A Imamura; M Fukayama; T Tsunoda; Y Sakaue; M Sakamoto; H Sagara
Journal:  Epidemiol Infect       Date:  2004-01       Impact factor: 2.451

7.  Factors associated with the detection of Entamoeba histolytica in homosexual men.

Authors:  C L Law; J Walker; M H Qassim
Journal:  Int J STD AIDS       Date:  1991 Sep-Oct       Impact factor: 1.359

8.  The use of real-time PCR to identify Entamoeba histolytica and E. dispar infections in prisoners and primary-school children in Ethiopia.

Authors:  A Kebede; J J Verweij; T Endeshaw; T Messele; G Tasew; B Petros; A M Polderman
Journal:  Ann Trop Med Parasitol       Date:  2004-01

9.  Non-pathogenic entamoeba histolytica in Italian HIV-infected homosexuals.

Authors:  S Gatti; C Cevini; C Atzori; S Muratori; R Zerboni; M Cusini; M Scaglia
Journal:  Zentralbl Bakteriol       Date:  1992-10

10.  Entamoeba moshkovskii infections in children, Bangladesh.

Authors:  Ibne Karim M Ali; Mohammad Bakhtiar Hossain; Shantanu Roy; Patrick F Ayeh-Kumi; William A Petri; Rashidul Haque; C Graham Clark
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  45 in total

1.  Entamoeba moshkovskii is associated with diarrhea in infants and causes diarrhea and colitis in mice.

Authors:  Chikako Shimokawa; Mamun Kabir; Mami Taniuchi; Dinesh Mondal; Seiki Kobayashi; Ibne Karim M Ali; Shihab U Sobuz; Masachika Senba; Eric Houpt; Rashidul Haque; William A Petri; Shinjiro Hamano
Journal:  J Infect Dis       Date:  2012-06-21       Impact factor: 5.226

2.  Evaluation of multiplex tandem real-time PCR for detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples.

Authors:  D Stark; S E Al-Qassab; J L N Barratt; K Stanley; T Roberts; D Marriott; J Harkness; J T Ellis
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

3.  Case Report: Endemic Amebiasis in Australia: Implications for Residents, Travelers, and Clinicians.

Authors:  Simon Smith; Gael E Phillips; William J H McBride; Josh Hanson
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

Review 4.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

5.  Loop-mediated isothermal amplification (LAMP) assay for rapid detection of Entamoeba histolytica in amoebic liver abscess.

Authors:  Preeti Singh; Bijay Ranjan Mirdha; Vineet Ahuja; Sundeep Singh
Journal:  World J Microbiol Biotechnol       Date:  2012-10-06       Impact factor: 3.312

6.  Entamoeba moshkovskii infections in Sydney, Australia.

Authors:  R Fotedar; D Stark; D Marriott; J Ellis; J Harkness
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-24       Impact factor: 3.267

7.  Molecular epidemiology of amebiasis.

Authors:  Ibne Karim M Ali; C Graham Clark; William A Petri
Journal:  Infect Genet Evol       Date:  2008-05-14       Impact factor: 3.342

8.  Comparison of stool antigen detection kits to PCR for diagnosis of amebiasis.

Authors:  D Stark; S van Hal; R Fotedar; A Butcher; D Marriott; J Ellis; J Harkness
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

Review 9.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Detection of Entamoeba histolytica DNA in the saliva of amoebic liver abscess patients who received prior treatment with metronidazole.

Authors:  Krishna Khairnar; Subhash Chandra Parija
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.